CH
CVI Holdings Portfolio holdings
AUM
$116M
This Quarter Return
-13.26%
1 Year Return
+3.84%
3 Year Return
+23.84%
5 Year Return
+272.82%
10 Year Return
–
AUM
$86.6M
AUM Growth
+$86.6M
(-18%)
Cap. Flow
-$11.3M
Cap. Flow
% of AUM
-13.01%
Top 10 Holdings %
Top 10 Hldgs %
77.72%
Holding
92
New
34
Increased
1
Reduced
9
Closed
28
Top Buys
| 1 |
Comscore
SCOR
|
$14.1M |
| 2 |
Carisma Therapeutics
CARM
|
$12.2M |
| 3 |
MDCO
Medicines Co
MDCO
|
$4.12M |
| 4 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
$3.74M |
| 5 |
CALA
Calithera Biosciences, Inc
CALA
|
$3.29M |
Top Sells
| 1 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$18.5M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$16M |
| 3 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$8.16M |
| 4 |
GNFT
Genfit
GNFT
|
$5.17M |
| 5 |
Spyre Therapeutics
SYRE
|
$2.19M |
Sector Composition
| 1 | Healthcare | 33.38% |
| 2 | Communication Services | 20.11% |
| 3 | Consumer Staples | 4.12% |
| 4 | Industrials | 1.28% |
| 5 | Consumer Discretionary | 0.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Comscore
SCOR
$33.4M
| $14.1M | 16.25% | +2,728,513 | New | +$14.1M |
|
|
2
Carisma Therapeutics
CARM
$8.98M
| $12.2M | 14.05% | +8,112,882 | New | +$12.2M |
|
|
MDCO
3
DELISTED
Medicines Co
MDCO
| $4.12M | 4.75% | +112,950 | New | +$4.12M |
|
|
SRNE
4
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $3.74M | 4.32% | +1,401,640 | New | +$3.74M |
|
|
CALA
5
DELISTED
Calithera Biosciences, Inc
CALA
| $3.29M | 3.8% | +843,234 | New | +$3.29M |
|
|
EMWP
6
DELISTED
Eros Media World PLC
EMWP
| $2.83M | 3.27% | 2,098,602 +1,599,693 | +321% | +$2.16M |
|
|
GNFT
7
Genfit
GNFT
$200M
| $2.73M | 3.15% | 138,185 -261,815 | -65% | -$5.17M |
|
8
Scholar Rock
SRRK
$3.14B
| $2.66M | 3.06% | +167,371 | New | +$2.66M |
|
9
Laureate Education
LAUR
$4.05B
| $1.91M | 2.21% | +121,792 | New | +$1.91M |
|
|
ORTX
10
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $1.83M | 2.11% | +130,651 | New | +$1.83M |
|
11
Kura Oncology
KURA
$686M
| $1.2M | 1.38% | +60,800 | New | +$1.2M |
|
|
NTBL
12
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $1.18M | 1.36% | 908,770 -185,274 | -17% | -$241K |
|
13
Senmiao Technology Ltd
AIHS
$2.62M
| $1.11M | 1.28% | +398,302 | New | +$1.11M |
|
14
AquaBounty Technologies
AQB
$4.58M
| $1.06M | 1.22% | +345,202 | New | +$1.06M |
|
15
Cyclerion Therapeutics
CYCN
$7.91M
| $899K | 1.04% | +78,557 | New | +$899K |
|
|
TBIO
16
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $852K | 0.98% | +67,464 | New | +$852K |
|
17
EyePoint Pharmaceuticals
EYPT
$797M
| $748K | 0.86% | 455,810 -1,028,904 | -69% | -$1.69M |
|
|
ELOX
18
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $742K | 0.86% | +74,380 | New | +$742K |
|
19
Seres Therapeutics
MCRB
$166M
| $727K | 0.84% | +225,795 | New | +$727K |
|
|
RGLS
20
DELISTED
Regulus Therapeutics
RGLS
| $568K | 0.66% | +454,190 | New | +$568K |
|
21
Ekso Bionics
EKSO
$9.79M
| $494K | 0.57% | +388,601 | New | +$494K |
|
|
CTHR
22
DELISTED
Charles & Colvard Ltd
CTHR
| $452K | 0.52% | +285,854 | New | +$452K |
|
23
Arcadia Biosciences
RKDA
$5.28M
| $414K | 0.48% | +134,956 | New | +$414K |
|
24
Insmed
INSM
$28.8B
| $374K | 0.43% | +14,627 | New | +$374K |
|
25
Zymeworks
ZYME
$1.12B
| $373K | 0.43% | +16,956 | New | +$373K |
|